Aiplexity Investor Picks

Rescued readable June 12 screen facts from shell-corrupted notes while preserving exclusion, reclaim, solvency, and overextension lessons.

Sector-specific solvency adjustments prevent false Altman Z and liquidity flags for REITs, distributors, SaaS, healthcare, and defense primes.

ABM succeeded because a same-day earnings catalyst paired with an intraday reclaim, tight stop, and defensive beta beat higher-beta alternatives in a weak tape.

June 5 N/A avoided most reviewed AI/space losers but missed the later ABM post-earnings setup because discovery was too theme-anchored.

June 4 N/A was mostly right, but CRDO required a D+3 trigger-watch conversion after the first clear close above 222.35.

A slate-leading catalyst pick below key reclaim resistance must become N/A if execution cannot enforce the conditional trigger.

Pre-event run-ups with scheduled earnings within 14 days must be excluded from active 7-day picks to avoid binary event risk and implied volatility crush.

JCI failed because the prior-day breakout was not revalidated intraday before entry and collapsed through support and stop during the current session.

June 11 defense-prime audit kept RTX preferred over GD because RTX had fresher durable catalysts and better first-target reward/risk while GD was extended after its upgrade move.

Condensed June 2026 ticker research preserving AGX, DCI, EXPD, and INCY catalysts, solvency checks, technical gates, and clinical event risks.

Verified that screening tools compute ATR14 via Simple Moving Average of True Range rather than Wilder's EMA.

June 2026 candidate audit preserving standalone solvency, catalyst, financing, breakout, screen-method, and opportunity-cost facts without fragmented ticker notes.